NanoString
NanoString develops and commercializes cancer diagnostics tools.
Business Model:
Revenue: $135.3M
Employees: 501-1,000
Industries / Tags:
Detailed NanoString Information
Geographic Data
Address: 530 Fairview Avenue N.
City: Seattle
State: WA
Zip: 98109
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$230M
Raised Total:$52M
Social
Metrics
83,633Website Global Rank
1,259,762Website Monthly Traffic
Twitter Followers
Description
NanoString develops and commercializes cancer diagnostics tools.
Contact Phone:
+18883586266
Contact Email:
NanoString went public on 7/5/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/5/2013
Ticker Symbol:
NSTG
IPO Price:
$10/share
Amount Raised:
$54M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2019 | Post-IPO Equity | $68.3M | 7/2018 | Post-IPO Equity | $46.8M | 10/2020 | Post-IPO Equity | $230M | 3/2020 | Post-IPO Debt | $175M | 6/2017 | Post-IPO Equity | $56M | 4/2012 | Debt Financing | 2 | $15M |
Silicon Valley Bank Oxford Finance LLC |
4/2014 | Post-IPO Debt | 1 | $45M |
CRG CRG |
5/2013 | Venture Round | 3 | $150k |
Accelerator Corp. Threshold Clarus Ventures Accelerator Corp. Threshold Clarus Ventures |
4/2013 | Debt | $150k | 11/2011 | Equity | $20M | 12/2012 | Debt | $275k | 6/2013 | IPO | - | 11/2012 | Equity | $15.3M | 12/2012 | Series E | 7 | $15.3M |
AllianceBernstein Threshold Clarus Ventures GE Ventures OVP Venture Partners BioMed Ventures AllianceBernstein Morgan Stanley Expansion Capital AllianceBernstein Threshold Clarus Ventures GE Ventures OVP Venture Partners BioMed Ventures AllianceBernstein |
2/2010 | Venture Round | 1 | $15M |
Clarus Ventures Clarus Ventures |
4/2005 | Series A | 1 | $3.8M |
OVP Venture Partners OVP Venture Partners |
6/2011 | Debt Financing | $2.5M | 11/2011 | Series D | 5 | $20M |
Lysosomal Therapeutics OVP Venture Partners GE Healthcare Clarus Ventures BioMed Ventures |
6/2009 | Series C | 1 | $30M |
Clarus Ventures Clarus Ventures |
6/2007 | Series B | 1 | $8.5M |
OVP Venture Partners OVP Venture Partners |
6/2013 | IPO | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
